Assessment of Disease Activity, Function, and Quality of Life

Ankylosing Spondylitis and the Spondyloarthropathies

Volumn , Issue , 2006, Pages 206-213

  van der Heijde, Désirée ^a   Landewé, Robert ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42949146285     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03104-2.50019-3     Document Type: Chapter

References (25)

1. van der Heijde D, van der Linden S, Dougados M, Dougados M, Bellamy N, Russell AS Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol. 1999, 26:1003-1005.
2. van Tubergen A, Debats I, Ryser L, et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum. 2002, 47:242-248.
3. Auléley GR, Benbouazza K, Spoorenberg A, et al. Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis Rheum. 2002, 47:582-587.
4. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993, 20:579-581.
5. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum. 2001, 44:1876-1886.
6. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol. 1997, 24:2225-2229.
7. van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol. 1999, 26:951-954.
8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994, 21:2286-2291.
9. van Tubergen A, Coenen J, Landewé R, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum. 2002, 47:8-16.
10. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994, 21:2281-2285.
11. Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol. 1988, 15:302-307.
12. Daltroy LH, Larson MG, Roberts NW, Liang MH A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol. 1990, 17:946-950.
13. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 1994, 21:1694-1698.
14. Heuft-Dorenbosch L, Vosse D, Landewé R, et al. Measurement of spinal mobility in ankylosing spondylitis: comparison of occiputto-wall and tragus-to-wall distance. J Rheumatol. 2004, 31:1779-1784.
15. Gorman JD, Sack KE, Davis JC Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002, 346:1349-1356.
16. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002, 359:1187-1193.
17. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003, 62:127-132.
18. Wanders AJ, Landewé RB, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum. 2004, 50:2622-2632.
19. Stucki G. Understanding disability. Ann Rheum Dis. 2003, 62:289-290.
20. van Tubergen A, Landewé R, Heuft-Dorenbosch L, et al. Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis. 2003, 62:140-145.
21. Ware JE, Sherbourne CD The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30:473-483.
22. Guillemin F, Challier B, Urlacher F, Vancon G, Pourel J. Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res. 1999, 12:157-162.
23. Doward LC, Spoorenberg A, Cook SA, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003, 62:20-26.
24. Brandt J, Listing J, Sieper J, Rudwaleit M, van der Heijde D, Braun J. Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis. Ann Rheum Dis. 2004, 63:1438-1444.
25. Braun J, Davis J, Dougados M, Sieper J, van der Linden Sj, van der Heijide D. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2005;doi:10.1136/ard.2005.040758.